Vimarsana
Biggest News Aggregation in the World

Mathys Amp Squire News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mathys Amp Squire. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mathys Amp Squire Today - Breaking & Trending Today

UPC: 'A missed opportunity' as intervention bids in key case are throw - Vimarsana News

UPC: 'A missed opportunity' as intervention bids in key case are throw

The UPC Court of Appeal ‘narrowly’ interprets law in transparency test case | Court dismisses interventions by two law firms due to “legal interest” rules | Order sets high bar for intervention in UPC cases | Concerns over transparency persist; final decision expected in spring 2024.

Apple Watch latest: Fed Circ hands Apple PTAB win - Vimarsana News

Apple Watch latest: Fed Circ hands Apple PTAB win

Court's ruling reinforces the PTAB's decision that two claims in Masimo's patent for blood oxygen measurement technology are unpatentable | Decision significant in the context of Apple's recent injunction at the US ITC and the ongoing dispute concerning Apple Watch tech.

UPC sets hearing date for Ocado appeal, which could be pivotal for tra - Vimarsana News

UPC sets hearing date for Ocado appeal, which could be pivotal for tra

Demands for transparency at Unified Patent Court rests upon crucial hearing in Ocado v Autostore | Mathys & Squire’s separate ‘test’ case challenges future of p

'The EPO can manage it—I'm baffled why the UPC can't' - Vimarsana News

'The EPO can manage it—I'm baffled why the UPC can't'

Is the court’s public access rule unfit for purpose? Lawyers at Mathys & Squire are arguing for pleadings and evidence to be automatically made available on request, finds Muireann Bolger.

Mathys & Squire announces six partner promotions - Vimarsana News

Mathys & Squire announces six partner promotions

Moves enhance the firm’s expertise in supercomputing, AI, biomedical engineering, life sciences, and pharma | Mathys also announces the additional promotion of